Zobrazeno 1 - 10
of 42
pro vyhledávání: '"Sally F Shaw"'
Autor:
Deborah E Malden, Sara Y Tartof, Bradley K Ackerson, Vennis Hong, Jacek Skarbinski, Vincent Yau, Lei Qian, Heidi Fischer, Sally F Shaw, Susan Caparosa, Fagen Xie
Publikováno v:
JMIR Public Health and Surveillance, Vol 8, Iss 12, p e41529 (2022)
BackgroundNatural language processing (NLP) of unstructured text from electronic medical records (EMR) can improve the characterization of COVID-19 signs and symptoms, but large-scale studies demonstrating the real-world application and validation of
Externí odkaz:
https://doaj.org/article/624f73ba47a9409681536ec2d6c428fa
Autor:
Sara Y Tartof, Lei Qian, Liyan Liu, Devin Incerti, Jacek Skarbinski, Laura B Amsden, Bradley K Ackerson, Vennis Hong, Bruce H Fireman, Vincent M Yau, Heidi Fischer, Sally F Shaw
Publikováno v:
BMJ Open, Vol 12, Iss 10 (2022)
Objectives Assess the association between tocilizumab administration and clinical outcomes among mechanically ventilated patients with COVID-19 pneumonia.Design Retrospective cohort study.Setting Large integrated health system with 9 million members
Externí odkaz:
https://doaj.org/article/bbfd3cd482434b3584ba78b0efecad85
Autor:
Heidi Fischer, Lei Qian, Jacek Skarbinski, Katia J Bruxvoort, Rong Wei, Kris Li, Laura B Amsden, Mariah S Wood, Abigail Eaton, Brigitte C Spence, Sally F Shaw, Sara Y Tartof
Publikováno v:
PLoS ONE, Vol 17, Iss 8, p e0273363 (2022)
ObjectiveThough targeted testing for latent tuberculosis infection ("LTBI") for persons born in countries with high tuberculosis incidence ("HTBIC") is recommended in health care settings, this information is not routinely recorded in the electronic
Externí odkaz:
https://doaj.org/article/70362d3ad0d5425880b963ec295858b9
Autor:
Joseph A Lewnard, John M McLaughlin, Debbie Malden, Vennis Hong, Laura Puzniak, Bradley K Ackerson, Bruno J Lewin, Jeniffer S Kim, Sally F Shaw, Harpreet Takhar, Luis Jodar, Sara Y Tartof
Publikováno v:
The Lancet. Infectious diseases, vol 23, iss 7
BackgroundIn the USA, oral nirmatrelvir-ritonavir is authorised for use in patients aged 12 years or older with mild-to-moderate COVID-19 who are at risk of progression to severe disease and hospitalisation. We aimed to establish the effectiveness of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2c44cf3e9facb6c38b86da6b65a9c186
https://escholarship.org/uc/item/1cp1x02k
https://escholarship.org/uc/item/1cp1x02k
Autor:
Joseph A. Lewnard, Vennis Hong, Jeniffer S. Kim, Sally F. Shaw, Bruno Lewin, Harpreet Takhar, Marc Lipsitch, Sara Y. Tartof
Publikováno v:
Nature communications, vol 14, iss 1
Host immune responses are a key source of selective pressure driving pathogen evolution. Emergence of many SARS-CoV-2 lineages has been associated with enhancements in their ability to evade population immunity resulting from both vaccination and inf
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d296320afe1f6b4b4ca31ded95aa0c22
https://escholarship.org/uc/item/3rv1d4ws
https://escholarship.org/uc/item/3rv1d4ws
Autor:
Joseph A. Lewnard, Vennis Hong, Jeniffer S. Kim, Sally F. Shaw, Bruno Lewin, Harpreet Takhar, Sara Y. Tartof
Publikováno v:
Nature communications, vol 14, iss 1
Expansion of the SARS-CoV-2 BA.4 and BA.5 Omicron subvariants in populations with prevalent immunity from prior infection and vaccination, and associated burden of severe COVID-19, has raised concerns about epidemiologic characteristics of these line
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::512a081e6796eac99d547972ace7d723
https://escholarship.org/uc/item/18c4p9q2
https://escholarship.org/uc/item/18c4p9q2
Autor:
Simran K. Bhandari, Hui Zhou, Sally F. Shaw, Jiaxiao Shi, Natasha S. Tilluckdharry, Connie M. Rhee, Steven J. Jacobsen, John J. Sim
Publikováno v:
American Journal of Nephrology. 53:32-40
Introduction: Using a large diverse population of incident end-stage kidney disease (ESKD) patients from an integrated health system, we sought to evaluate the concordance of causes of death (CODs) between the underlying COD from the United States Re
Autor:
Deborah E Malden, Sara Y Tartof, Bradley K Ackerson, Vennis Hong, Jacek Skarbinski, Vincent Yau, Lei Qian, Heidi Fischer, Sally F Shaw, Susan Caparosa, Fagen Xie
Publikováno v:
JMIR public health and surveillance.
Background Natural language processing (NLP) of unstructured text from electronic medical records (EMR) can improve the characterization of COVID-19 signs and symptoms, but large-scale studies demonstrating the real-world application and validation o
Autor:
Joseph A. Lewnard, John M. McLaughlin, Debbie Malden, Vennis Hong, Laura Puzniak, Bradley K. Ackerson, Bruno J. Lewin, Jeniffer S. Kim, Sally F. Shaw, Harpreet Takhar, Luis Jodar, Sara Y. Tartof
Publikováno v:
medRxiv
BackgroundIn the United States, oral nirmatrelvir-ritonavir (Paxlovid™) is authorized for use among patients aged ≥12 years with mild-to-moderate SARS-CoV-2 infection who are at risk for progression to severe COVID-19, including hospitalization.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f87211005b63a568904df4ba80392dab
https://doi.org/10.1101/2022.10.02.22280623
https://doi.org/10.1101/2022.10.02.22280623
Autor:
Steven J. Jacobsen, Jonathan R. Neyer, John J. Sim, Ming-Sum Lee, Sally F. Shaw, Kamyar Kalantar-Zadeh, Csaba P. Kovesdy, Jiaxiao Shi, Hui Zhou
Publikováno v:
American Journal of Kidney Diseases. 77:704-712
Rational & Objective Beta-blockers are recommended for patients with heart failure (HF) but their benefit in the dialysis population is uncertain. Beta-blockers are heterogeneous, including with respect to their removal by hemodialysis. We sought to